補足図S1：膵管腺癌の前臨床モデルにおけるRAS(ON)多選択的阻害による腫瘍退縮および完全応答のT細胞依存性

Orlenら（Mon,）がこの問題を研究した。

www.synapsesocial.com/papers/689a0f93e6551bb0af8d10f3 — DOI: https://doi.org/10.1158/2159-8290.29819722

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure S3 from T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma· 2025
2. Supplementary Figure S5 from T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma· 2025
3. Supplementary Figure S4 from T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma· 2025
4. Supplementary Figure S2 from T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma· 2025
5. Supplementary Figure S12 from T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma· 2025